nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRNA1—tongue—amyotrophic lateral sclerosis	0.0874	0.34	CbGeAlD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0243	0.0327	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0224	0.0302	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0207	0.0278	CbGpPWpGaD
Metocurine—CHRNB1—medulla oblongata—amyotrophic lateral sclerosis	0.0207	0.0805	CbGeAlD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0198	0.0267	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0197	0.0264	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0191	0.0257	CbGpPWpGaD
Metocurine—CHRNB1—spinal cord—amyotrophic lateral sclerosis	0.0184	0.0718	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0183	0.0246	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0181	0.0244	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0169	0.0227	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0169	0.0227	CbGpPWpGaD
Metocurine—CHRNA2—nervous system—amyotrophic lateral sclerosis	0.0167	0.065	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0163	0.0219	CbGpPWpGaD
Metocurine—CHRNA2—central nervous system—amyotrophic lateral sclerosis	0.0161	0.0626	CbGeAlD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.016	0.0216	CbGpPWpGaD
Metocurine—CHRNA2—cerebellum—amyotrophic lateral sclerosis	0.0157	0.0612	CbGeAlD
Metocurine—CHRNA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0155	0.0209	CbGpPWpGaD
Metocurine—CHRNA1—brain—amyotrophic lateral sclerosis	0.0154	0.0599	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0149	0.0201	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0148	0.0199	CbGpPWpGaD
Metocurine—CHRNB1—cerebellum—amyotrophic lateral sclerosis	0.0146	0.0569	CbGeAlD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0144	0.0193	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.014	0.0189	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0139	0.0186	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0139	0.0186	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0139	0.0186	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0136	0.0183	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0132	0.0177	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0129	0.0174	CbGpPWpGaD
Metocurine—CHRNA2—brain—amyotrophic lateral sclerosis	0.0128	0.0497	CbGeAlD
Metocurine—CHRNA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0127	0.0171	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0125	0.0168	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0124	0.0166	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.012	0.0162	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0119	0.016	CbGpPWpGaD
Metocurine—CHRNB1—brain—amyotrophic lateral sclerosis	0.0119	0.0462	CbGeAlD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0118	0.0159	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0118	0.0159	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0114	0.0154	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0113	0.0152	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0112	0.0151	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0112	0.0151	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.011	0.0148	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0106	0.0143	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0106	0.0143	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0106	0.0143	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0105	0.0141	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0104	0.0141	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0101	0.0136	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00998	0.0134	CbGpPWpGaD
Metocurine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00995	0.0388	CbGeAlD
Metocurine—CHRNA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00971	0.0131	CbGpPWpGaD
Metocurine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00958	0.0373	CbGeAlD
Metocurine—CHRND—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00946	0.0127	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00923	0.0124	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00903	0.0121	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00903	0.0121	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00891	0.012	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00858	0.0115	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00858	0.0115	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00805	0.0108	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00765	0.0103	CbGpPWpGaD
Metocurine—CHRM2—brain—amyotrophic lateral sclerosis	0.00761	0.0296	CbGeAlD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.00678	0.00912	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00574	0.00772	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00574	0.00772	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00574	0.00772	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00413	0.00556	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00329	0.00442	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00297	0.00399	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.0025	0.00337	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.0018	0.00243	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00148	0.002	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00144	0.00193	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00141	0.0019	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00128	0.00173	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00126	0.00169	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00109	0.00147	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.001	0.00135	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000942	0.00127	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000893	0.0012	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000864	0.00116	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000768	0.00103	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000759	0.00102	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000635	0.000854	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000618	0.000831	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000561	0.000754	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000521	0.000702	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000489	0.000658	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000466	0.000627	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000399	0.000536	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000375	0.000504	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000331	0.000446	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000308	0.000415	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000255	0.000343	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000196	0.000264	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000185	0.000249	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000166	0.000224	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000126	0.000169	CbGpPWpGaD
